Caesium-137 reacts with water, producing a water-soluble compound (caesium hydroxide). The biological behaviour of caesium is similar to that of potassium and rubidium. After entering the body, caesium gets more or less uniformly distributed throughout the body, with the highest concentrations in soft tissue.  However, unlike group 2 radionuclides like radium and strontium-90, caesium does not bioaccumulate and is excreted relatively quickly. The biological half-life of caesium is about 70 days.
A 1961 experiment showed that mice dosed with 21.5 μCi/g had a 50% fatality within 30 days (implying an LD of 245 μg/kg). A similar experiment in 1972 showed that when dogs are subjected to a whole body burden of 3800 μCi/kg (140 MBq/kg, or approximately 44 μg/kg) of caesium-137 (and 950 to 1400 rads), they die within 33 days, while animals with half of that burden all survived for a year.  Important researches have shown a remarkable concentration of Cs in the exocrine cells of the pancreas, which are those most affected by cancer. In 2003, in autopsies performed on 6 children who died in the polluted area near Chernobyl (of reasons not directly linked to the Chernobyl disaster; mostly sepsis), where they also reported a higher incidence of pancreatic tumors, Bandazhevsky found a concentration of Cs 3.9 times higher than in their livers (1359 vs 347 Bq/kg, equivalent to 36 and 9.3 nCi/kg in these organs, 600 Bq/kg = 16 nCi/kg in the body according to measurements), thus demonstrating that pancreatic tissue is a strong accumulator and secretor in the intestine of radioactive cesium.
Accidental ingestion of caesium-137 can be treated with Prussian blue (Fe[Fe(CN)]), which binds to it chemically and reduces the biological half-life to 30 days.